chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient under 65 received Fluad QIV; Aches; Injection site pain; Chills; Muscle soreness; This spontaneous case received on 05-Nov-2020 from other health professional (nurse) via Agency (reference number: SEQW20-04830) and concerned a 46-year-old, male patient.   The patient had no relevant medical history. The patient's concomitant medications were not reported.   On 29-Sep-2020, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid) (explicitly coded as 'Inappropriate age at vaccine administration') for influenza prophylaxis. The batch number reported was 286592.   On an unspecified date in 2020, unknown time after receiving Fluad Quadrivalent, the patient experienced injection site pain, muscle soreness, aches and chills. The patient's corrective treatment associated with the events included Tylenol (paracetamol), ibuprofen and Sudafed (xylometazoline hydrochloride).  The outcome of the events was not reported.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  The case is linked to the cases 202004845, 202006068, 202006069, 202006072, 202006074, 202006080, 202006081, 202006084, 202006085, 202006086, 202006087, 202006089, 202006090, 202006091, 202006092, 202006095, 202006097 and 202006098 (the same reporter).  Company comment: A 46-year-old, male patient was vaccinated with Fluad Quadrivalent. An unknown amount of time after receiving Fluad Quadrivalent, the patient developed pain, chills, myalgia and vaccination site pain. With information available, causal role of the suspect vaccine is assessed as possibly related. Product administered to patient of inappropriate age is assessed as not related, per company's conventions.; Sender's Comments: A 46-year-old, male patient was vaccinated with Fluad Quadrivalent. An unknown amount of time after receiving Fluad Quadrivalent, the patient developed pain, chills, myalgia and vaccination site pain. With information available, causal role of the suspect vaccine is assessed as possibly related. Product administered to patient of inappropriate age is assessed as not related, per company's conventions.
Significant left eye twitching, with involuntary eye closure for a second, that occurred every 3-10 minutes starting 2/5/21-2/8/21. Minimal occurrence on 2/8/21. Instructed to see hospital Ophthalmologist today.
At night I felt fatigue and palpitations and could not sleep. Next morning the palpitations and fatigue went away but I start with a rash and very itchy and noticed my face swelling up. I took some prednisone I had home and Benadryl and went to the ER. They monitored me and medicated me and told me to keep with the Benadryl. On the 24th I started with the rash and on the 26th no more rash. My second dose is scheduled on the 13th and I will see my PCP on the 12th to decide if I should have the second dose. I am not allergic to anything and thought I would die on 12/24. I was swelling up in less than a minute after I woke up it was awful. I also have a consultation with an allergist on Tuesday  before the vaccine.
This spontaneous report was received from a medical assistant concerning 11 unspecified patients of unknown age and gender. The pertinent medical history and concurrent conditions were not reported. On an unknown date, 4 patients were vaccinated with GARDASIL 9 injection, lot # L044475, expiration date: 12-MAY-2017 (dose, route and anatomical location of administration were not reported); and 7 patients were vaccinated with GARDASIL 9 injection, lot # M003659, expiration date: 20-SEP-2017 (dose, route and anatomical location of administration were not reported); which were improperly stored. The lowest temperature excursion reported was 33.3 F for 2 hours and the highest temperature was 46.6 F for 30 minutes. The temperature excursion was detected by a digital data logger. No adverse effects were reported and no product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Raised welt, warm, reddish, throbbing and about 2" x 5".
Mother states had fever of 101 - 102. She gave him Tylenol for the fever. The child exhibited stiffness ad rigidity and was thrashing his head. These episode occured 3- 4 times a day for 2 weeks and then stopped. Mother stated she called her MD and was told to watch the child.
Right leg with 2.5x4 cm knot red/ hot / firm observed 8/30/04. Fever 103 onset. Friday 8/27/04 with URI onset 8/28/04.
Flu Like Symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu Like Symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 025J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu Like Symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu Like Symptoms) outcome was unknown.            No relevant concomitant medications were reported. No treatment medications were reported.
Patient had an allergic reaction to moderna vaccine dose 2. Pt started having tightness of chest and hyperventilation. BP was 159/80 hr 117 o2 100%. Pt given benadryl IM 50mg. Pt started complaining of shaking and progessively got worse. Epipen was administered. 911 was called. Ambulance came within 5 mins of epipen administration
Information has been received from a physician reporting on her approximately 81 year old father with no cancer or radiation history and no shingles previous to having ZOSTAVAX (Merck), who in 2011, was vaccinated with a dose of ZOSTAVAX (Merck), 0.65ml (route and lot number not reported). Concomitant therapy included CRESTOR, lisinopril (manufacturer unknown), PLAVIX and "CREG". It was reported that the patient received ZOSTAVAX (Merck) in 2011 and approximately 8 weeks later the patient telephoned his daughter and reported a rash on his eye lid, face, and scalp which had started over 3 days ago. The reporter did not treat the shingles rash since it was greater than three days. For the past several months the patient was been complaining of eye pain and he thought it was cataract. On 30-JAN-2012, the patient was seen by ophthalmologist who diagnosed the patient having zoster in his cornea. The patient was being treated with VALTREX and PRED FORTE) eye drops. At the time of the report, the patient had decreased vision and pain in his eye (unknown) if it was his right or left eye) and did not have any rash or lesions on the face or eye lid. At the time of the report, the patient's outcome was not recovered. Zoster in his cornea, shingles rash on his eye lid, face and scalp, pain in his eye and decreased vision were considered to be disabling. Additional information has been requested.
Information has been received from a physician via a company representative concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history or concomitant medications were not reported. On 18-JUL-2016, the patient was vaccinated with a dose of PNEUMOVAX 23, 0.5 mL, (lot number L035882, with an expiration date of 19-APR-2017) (route and anatomical location were not reported) that was improperly stored. On an unspecified date, the PNEUMOVAX 23 vaccine had a temperature excursion. The lowest temperature excursion was of 34 Fahrenheit (F), (1.111111111 Celsius degrees) for a total of 176 hours. No adverse effects were reported. The vaccine storage criteria and the type of the excursion were reported as refrigerator (R), and the vaccine status was reported as "in excursion". Furthermore, no product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
devel petichiae p/vax 15MAY97;rash noted 25MAY97;ofc visit 2JUN97 & platelet ct <8000;diffuse petechiae & bruising;
7/29 pt reports headache began. Pain was in head, neck, upper back and shoulders. General body aches with joint pain. by 8/15/07 pt still reporting headaches not relieved by Tylenol or Motrin. Also decreased sleeping, increased urination and dark urine. Pt reports has been to MD and awaiting follow up lab results.
Rash blisters with clear fluid forming on neck back and chest.; Rash blisters with clear fluid forming on neck back and chest.; Burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor prescribed shingles medication and tramadol; Burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor prescribed shingles medication and tramadol; prescribed shingles medication; This is a spontaneous report from a contactable other healthcare professional (patient). A 56-year-old male patient receive second single dose of BNT162B2 (Pfizer, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration (vaccine location: Left arm) on 17Jan2021 13:15 for Covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered: Nursing Home/Senior Living Facility. There was no relevant medical history. Patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first single dose of BNT162B2 (Pfizer) on 27Dec2020 14:00, vaccine location: Left leg, for Covid-19 immunization. On 18Jan2021 06:00, the patient experienced rash blisters with clear fluid forming on neck, back, and chest. There was also burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor wherein patient was prescribed shingles medication and tramadol. The events were considered as non-serious by the reporter. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient was recovering from pustule while the outcome of the other events was not recovered.  Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.
Pt felt like she was going to faint and became hypotensive (84/49, 72/41) pt rested had water and BP came back up after approximately 5 mins to 104/71.
Rash on left arm at injection site. Approximately 2" in diameter. Area is hard and hot to the touch.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. In January 2016, the patient was vaccinated with GARDASIL 9 dose 1 for prophylaxis. In March 2016, the patient experienced inappropriate schedule of drug administration. On an unknown date the patient experienced no adverse event.
Dizziness, Headache, Myalgia, Arthralgia, Anaphylaxis, UrticariaPruritus, Large hives involving my left eyelid and then my right eyelid/Fever max 102.4 Narrative:  Discussed reactions with my immunologist, Dr.--Clinic. He stated this was an allergic reaction and I should not have the second dose of COVID.
In the 8th day of 1st dose, I felt severe headache and mild swallowed and warm, itchy and pain on the area of injecting.  I took Tylenol and the headache went away in about 7-8 hours.  Other symptoms went away by themselves in 3-4 days.  One the six night of the 2nd dose, I felt sharp abnormal pain. It started to bleed on the 7th day and is getting a bit heavier  than usual.  If it is period, then it?s two weeks earlier.  Today is the 8th of 2nd dose, still heavier than normal period.  Yesterday I hurt my finger by a needle,  I couldn?t stop the bleeding right away.  It was quite a lot of blood than normal.  My hand was all red.  Right after the 2nd dose, I had 4-5 days of headache, two days of them were severe.  I took Tylenol but it didn?t help a lot.
My body broke out into hives 2-4 hours after receiving the vaccine. This lasted approx 4 days, while taking Benedryl for symptoms.   I broke out into hives again on 6/21/2021 and they are still present on 7/8/2021.
Went into the hospital/he went in for other problems not because of the injection; Product dose omission; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ILL-DEFINED DISORDER (Went into the hospital/he went in for other problems not because of the injection) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included AMLODIPINE, ACETYLSALICYLIC ACID (ASPRIN), PREDNISONE and METOPROLOL for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILL-DEFINED DISORDER (Went into the hospital/he went in for other problems not because of the injection) (seriousness criterion hospitalization) and PRODUCT DOSE OMISSION ISSUE (Product dose omission). The patient was hospitalized from 25-Mar-2021 to 20-May-2021 due to ILL-DEFINED DISORDER. At the time of the report, ILL-DEFINED DISORDER (Went into the hospital/he went in for other problems not because of the injection) and PRODUCT DOSE OMISSION ISSUE (Product dose omission) outcome was unknown.            Treatment information was not reported.  On 25-Mar-2021 he was admitted into the hospital and was there for 8 days and was out for 4 days and then he went back in and stayed in in the hospital for 20 days and went back in back in two days later and stayed for 16 days then was released on 20-May-2021 and had been home since. Patient's wife stated that was why he was received his second dose so late, because he had been in the hospital. She denied patient had any adverse reaction from the Moderna Covid-19 injection.  Company comment: Based on current available information and the lack of temporal association between product use and the start date of the event a causal relationship is unlikely.   This case was linked to MOD-2021-187082 (Patient Link).; Sender's Comments: Based on current available information and the lack of temporal association between product use and the start date of the event a causal relationship is unlikely.
whole body muscle weakness and pain, pruritus, constipation  Antibiotic treatment and skin cortisone ointment probiotics vitamins B1,12,, D,
Mom states patient fine yesterday 3/27 - Developed cough which is worse lying down. States fever but not taken.
Pruritic urticarial rash; Pruritic urticarial rash; This spontaneous case was received on 07-Dec-2020 from a physician via Med Communications (reference number: SEQW20-05632) and concerned a 57-year-old female patient.   The patient's concurrent condition included high cholesterol and palpitations. The patient's concomitant medications included Crestor (rosuvastatin calcium), levothyroxine, metoprolol and trazodone, all used for an unreported indication.  On 04-Dec-2020, the patient was vaccinated with Flucelvax QIV vaccine (influenza vaccine, subunit influenza virus vaccine polyvalent; dose: 0.5 ml, route of administration: intramuscular and anatomical location: arm) for influenza prophylaxis. The batch number reported was 279841 and expiration date: 20-Jun-2021.    On 05-Dec-2020, one day after receiving Flucelvax QIV, the patient developed pruritic urticarial rash.   On an unspecified date in Dec-2020, the patient was treated with Benadryl (diphenhydramine hydrochloride) and prednisone for the events.  At the time of initial reporting on 07-Dec-2020, the patient was recovering from the event, as it was reported that the patient was feeling better.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: The both events are assessed as related to Flucelvax QIV vaccine.; Sender's Comments: The both events are assessed as related to Flucelvax QIV vaccine.
Sore upper R arm at injection site, headache, severely swollen lymph-nodes under R armpit
C/O "stomach ache" after receiving Flumist. PC to mother @ 12:20 pm- child remained @ school. Recovered at school.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 05-OCT-2018 the patient received an expired dose of GARDASIL 9 (intramuscular, lot# M028323 and expiration date 26-SEP-2018, dose was not reported) for prophylaxis. No known adverse effects were reported.
Left clavicle pain with point tenderness over the bone (not the muscle) no lymphadenopathy. Pain lasted few days and seems to start to improve today.
I received the vaccine and I was okay until about January and I got Covid-19 and then I started to having issues with my memory, and having shortness of memory. Also, my eyesight has changed.
Asymptomatic breakthrough COVID infection. Swab collected 08/11/2022. Tested as part of routine screening on admission to hospital.
Patient reported severe pain in both arms and legs the night after injections. She described the pain as severe and sharp and unbearable, and she was unable to sleep all night. Following day she experienced flu like symptoms.
On 4-16-09 around 11:30 A.M. had vaccine within minutes felt light-headed and woozy, strong feeling about 2 hrs, then took 3hr nap and gone when I awoke.
Approximately 2 day after vaccine started feeling something recurring through veins through body. Became flu like symptoms, weakness in upper and lower extremities. Could not eat or get out of bed mucus in throat.
Ringing tones in both ears, was occasional, now happening most of the day, seems like more bothersome in the evening, night time. Heightened sensitivity to sounds. Had some mild dizziness but not experiencing that now.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age. The patient was vaccinated with the first, second and third dose of GARDASIL (Lot#, dose and route not reported) on 16-MAR-2010, 18-JAN-2011 and 05-OCT-2012 respectively. The patient did not experience any known symptoms. It was not known if the patient sought for medical attention. Additional information has been requested.
Pharmacist intended to administer bivalent vaccine, but regular pfizer (non-bivalent) was given by mistake as patient's 5th dose.
HCP believed it was an infection caused by the injection; Pain in her entire right leg; redness,Red spot on her arm that was hurting a lot; Reaction spread more and more and was hurting and itching; Aches,Pains all over; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE INFECTION (HCP believed it was an infection caused by the injection), PAIN IN EXTREMITY (Pain in her entire right leg), ERYTHEMA (redness,Red spot on her arm that was hurting a lot), PRURITUS (Reaction spread more and more and was hurting and itching) and PAIN (Aches,Pains all over) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFECTION (HCP believed it was an infection caused by the injection), PAIN IN EXTREMITY (Pain in her entire right leg), ERYTHEMA (redness,Red spot on her arm that was hurting a lot), PRURITUS (Reaction spread more and more and was hurting and itching) and PAIN (Aches,Pains all over). The patient was treated with ANTIBIOTICS-RESISTANT LACTIC ACID BACTERIAE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INFECTION (HCP believed it was an infection caused by the injection), PAIN IN EXTREMITY (Pain in her entire right leg), ERYTHEMA (redness,Red spot on her arm that was hurting a lot), PRURITUS (Reaction spread more and more and was hurting and itching) and PAIN (Aches,Pains all over) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Information has been received from a medical assistant concerning a 11 year old male patient who on 15-MAY-2008, was vaccinated with a dose of RECOMBIVAX HB (lot #657461/1610U) by accident. The patient was given an order of VARIVAX (Merck) by the physician but was given a dose of RECOMBIVAX HB. The patient received the series in 1997. The error was found when the medical assistant called to confirm which vaccine was associated with a particular lot number. The patient was not experiencing any known symptoms. Follow-up information was received from the physician who reported that the patient was healthy. The physician considered that hepatitis A virus vaccine and RECOMBIVAX HB was given by mistake. No adverse reactions was recorded or noted by either parent or physician. No further information is available.
first shot my arms and neck muscles went numb for several hours  Second time my legs were in severe pain and hard to make move-could barely walk. This lasted for about 8  hours. I had a small fever, my left leg and ankle swelled for several days and hurt mildly.  I had a rash on my neck and body. I had fatigue  like theonset of a fibro attack both times but second shot was much worst than first.
Vaccinated with Varivax on 01/18/00. Reported dx of chickenpox 04/29/03.
Dose 1 was given on 1/9/21.  Dose 2 was given on 2/6/21 Lot #042L20A. 12 hours after receiving the 2nd dose I had chills, and had a fever that reached 103 degrees.  I was very tired & had body aches.  The symptoms stopped approximately  24 hours later.   The morning of 6/29/21 at approximately 5:30 am, as I was getting ready for work, my upper body became numb & collapsed.  I began coughing & coughed up frank blood.  I was lethargic & having difficulty keeping my eyes open, and chest pain on my right side.  I was transported to  Hospital via ambulance.    My troponin levels were elevated & after a Chest CT, they found a lung nodule on my upper right lung.  I was diagnosed with myocarditis & the lung nodule.  I was hospitalized & had an echocardiogram the next day.  After being discharged home, I felt normal, other than some pain in my chest when I would cough or sneeze.   On July 7th, my chest pain became worse.  I was unable to contact my PCP, therefore I went back to the ER.  My troponin levels were normal & was given tramadol and a lidocaine patch for the pain.  Since then I have had a "dull" pain in my right chest, however I have not had to take any medications for this.
Felt itching around mouth and tip of tongue 20 minutes after receiving vaccine stated she thought it was just nerves or anxiety
I returned home from receiving the vaccine dose, went to my desk to prepare to teach (university literature course on Zoom), and my vision had degraded and distorted in my right eye such that I could not easily read the screen in the same configuration. I followed up with my opthamologist who said it looked like the dry macular degeneration had become wet macular degeneration. I saw Dr. who examined and treated with monthly shots of Avastin for 6 months with no improvement. We switched for three injections, which also did not help. I consulted Dr. who did an angiography test of the eye 6 weeks ago and provisionally diagnosed it as a genetic retinal disease because fluid wasn't actively leaking in the eye. My vision continues to be distorted and I have a follow up appointment next month.